Patent ID: 7585972

Claim:
Crystalline (9S-(9α,10β,12α))-2,3,9,10,11,12-hexahydro-10-hydroxy-10-(methoxycarbonyl)-9-methyl-9,12-epoxy-1H-diindolo[1,2,3-fg:3′,2′,1′-kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one bis(tetrahydrofuranate) characterized in the orthorhombic crystal system and P2 1 2 1 2 1 space group, when measured at about −100° C. with Mo—Kα radiation, by lattice parameters a, b and c of 7.4514 Å±0.009 Å, 11.892 Å±0.001 Å and 32.960 Å±0.04 Å, respectively.